Wouters, E., Postma, D., Fokkens, B., Hop, W., Prins, J., Kuipers, A., . . . t for. (2005). Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: A randomised controlled trial. BMJ Group.
Chicago Style CitationWouters, E., et al. Withdrawal of Fluticasone Propionate From Combined Salmeterol/fluticasone Treatment in Patients With COPD Causes Immediate and Sustained Disease Deterioration: A Randomised Controlled Trial. BMJ Group, 2005.
Cita MLAWouters, E., et al. Withdrawal of Fluticasone Propionate From Combined Salmeterol/fluticasone Treatment in Patients With COPD Causes Immediate and Sustained Disease Deterioration: A Randomised Controlled Trial. BMJ Group, 2005.